StockData
Park Dental Partners, Inc. logo

Park Dental Partners, Inc. (PARK) company profile

PARKNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$19.36−0.36 (-1.83%)

Close on Nov 17, 2026Market cap $92.06MP/E –Yield –

About Park Dental Partners

Services-Misc Health & Allied Services, NEC, SIC 8090

Park Dental Partners, Inc. operates as a dental resource organization that delivers business support services to affiliated dental practices. The company supplies clinical support staff, administrative personnel, facilities, equipment, and centralized administrative functions such as billing, collections, scheduling, and information technology. Through long-term agreements, its affiliated network provides general and specialty dental care, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. Its direct clients are affiliated dental practices, while the network serves individual patients seeking preventative, routine, and specialized oral care.

The organization supports 86 practice locations across Minnesota, Wisconsin, and Arizona, with its largest concentration of operations located in the Minneapolis and St. Paul metropolitan area. Its supported network includes 214 dentists along with 990 hygienists, dental assistants, and patient care coordinators. The enterprise is incorporated in Minnesota.

Summary of the business section of Park Dental Partners's latest annual report, written by StockData.

Company profile

Company

Legal name
Park Dental Partners, Inc.
Founded
1972
Headquarters
Roseville, MN
Address
2200 County Road C West, Suite 2210 55113
Phone
(651) 633-0500
Employees
1,212, Dec 31, 2025
Industry
Services-Misc Health & Allied Services, NEC
Incorporated in
Minnesota
Fiscal year ends
December 31

Stock & identifiers

Ticker
PARK
Exchange
Nasdaq
IPO date
Dec 3, 2025
Shares outstanding
5M, Aug 13, 2026
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
2069604
CUSIP
700402100
ISIN
US7004021009
FIGI
BBG01X1GFQB3
Share class FIGI
BBG01X1GFRT2
LEI
529900JGYNTREBZJHT94
EIN
93-2020683

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Alan Siems LawSee Remarks, Director181,001
Peter G. SwensonCEO and Chairman, Director238,381
Christopher James BernanderChief Financial Officer, Director55,756
Christopher Eugene SteeleSee Remarks, Director137,172
Philip Irving SmithDirector3,569
Anna Marie SchaeferDirector2,800
Christopher Charles SmithDirector10,492
Todd Christopher GerlachDirector68,847

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusOtherTotalvs. prior year
Christopher J. Bernander
Chief Financial Officer, Treasurer
$425.00K$274.71K$16.14K$715.85K-27%
Dr. Alan Law
Chief Clinical Officer, Specialty Practices
$675.28K$96.96K$106.29K$878.53K-12%
Dr. Christopher Steele
Chief Clinical Officer, General Practices
$529.34K$193.91K$18.63K$741.87K-5%
Peter G. Swenson
Chairman of the Board, President and Chief Executive Officer
$602.55K$584.21K$19.40K$1.21M-54%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Dec 3, 2025
Offer price
$13.00
Securities offered
1,535,000
Gross proceeds
$19.96M
Exchange
Nasdaq
First trading day
Dec 3, 2025
First-day close
$10.25-21.2%
Lock-up ends (est.)
Jun 1, 2026

“The initial public offering price of our Common Stock is $13.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?